Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 309

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 309
---
 be determined, for the grant, issue or sale of such Purchase
Rights.

Fundamental Transactions

In the event of a fundamental
transaction, as described in the Offered Common Warrants and generally including any reorganization, recapitalization or reclassification
of our Common Stock, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation
or merger with or into another person, the consummation of a business combination with another person or group of persons whereby such
other person or group acquires greater than 50.1% of the voting power of the outstanding Common Stock and preferred stock, the holders
of the Offered Common Warrants will be entitled to receive upon exercise of the Offered Common Warrants the kind and amount of securities,
cash or other property that the holders would have received had they exercised the Offered Common Warrants immediately prior to such
fundamental transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the holder may require
the Company or its successor to repurchase the Offered Common Warrants for its Black-Scholes Value (as defined in the Offered Common
Warrants) in cash. This right can be exercised concurrently with, or within 30 days following, the consummation or public announcement
of the transaction. If the Fundamental Transaction occurs outside the Company’s control, such as in a hostile takeover or an unapproved
transaction, the holder is entitled to receive consideration equivalent in type and proportion to that offered to common stockholders,
also calculated based on the Black-Scholes model. Additionally, if no consideration is offered to the Company’s stockholders in
the transaction, the holder is deemed to receive common stock of the successor entity, preserving the Offered Common Warrants value.

<div align='center'>181</div>

Transferability

Subject to applicable laws,
the Offered Common Warrants may be offered for sale, sold, transferred or assigned. There is currently no trading market for the Offered
Common Warrants and a trading market is not expected to develop.

Rights as a Stockholder

Except as otherwise provided
in the Offered Common Warrants or by virtue of a holder’s ownership of shares of our Common Stock, the holders of the Offered Common
Warrants do not have the rights or privileges of holders of our Common Stock, including any voting rights, unless and until they exercise
their Offered Common Warrants.

Amendments

The Offered Common Warrants